Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults

scientific article published on 27 September 2007

Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.GHIR.2007.08.004
P932PMC publication ID2492581
P698PubMed publication ID17904401
P5875ResearchGate publication ID5941318

P50authorAnne B. NewmanQ21401975
Howard D StricklerQ89146137
Swapnil RajpathakQ92544163
Aileen P McGinnQ117248711
Bruce M. PsatyQ30429993
Elsa S. StrotmeyerQ42639734
Anne CappolaQ88050382
Lewis KullerQ88077314
P2093author name stringRobert C Kaplan
Michael Pollak
Thomas E Rohan
XiaoNan Xue
P2860cites workProvision or distribution of growth hormone for "antiaging": clinical and legal issuesQ28279021
The Cardiovascular Health Study: design and rationaleQ29614874
Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusQ29616284
Insulin-like growth factors (IGFs): implications for agingQ35149804
Serum levels of insulin-like growth factor I and its binding proteins in health and diseaseQ35197911
Free insulin-like growth factors -- measurements and relationships to growth hormone secretion and glucose homeostasisQ35874079
Molecular interactions of the IGF systemQ36152450
Aging somatotropic axis: mechanisms and implications of insulin-like growth factor-related binding protein adaptationQ36323530
Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control studyQ38487837
Stimulation of insulin-like growth factor binding protein-1 synthesis by interleukin-1beta: requirement of the mitogen-activated protein kinase pathwayQ40857963
Insulin-like growth factor binding protein-1: recent findings and new directions.Q41663650
Liver-specific igf-1 gene deletion leads to muscle insulin insensitivityQ43596024
No decrease in free IGF-I with increasing insulin in obesity-related insulin resistanceQ43763142
Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational studyQ44017895
Free and total insulin-like growth factor (IGF)-I levels decline during fasting: relationships with insulin and IGF-binding protein-1.Q44018225
Family history of type 2 diabetes is associated with decreased insulin sensitivity and an impaired balance between insulin sensitivity and insulin secretion in white youthQ45199384
Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose toleranceQ45199388
A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarctionQ45262915
Altered response of insulin-like growth factor-binding protein 1 to nutritional deprivation in type 2 diabetes mellitusQ45286373
Role of insulin-like growth factor iin maintaining normal glucose homeostasisQ46371076
Maternal plasma concentrations of IGF-1, IGFBP-1, and C-peptide in early pregnancy and subsequent risk of gestational diabetes mellitusQ46783769
The impact of abnormalities in IGF and inflammatory systems on the metabolic syndromeQ47627541
Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin-dependent diabetes mellitusQ47645417
Metabolic, anthropometric, and nutritional factors as predictors of circulating insulin-like growth factor binding protein-1 levels in middle-aged and elderly men.Q47799021
Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic strokeQ48797065
Regulation of insulin-like growth factor (IGF)-I mRNA and peptide and IGF-binding proteins by interleukin-1.Q49083892
Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.Q51559519
Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.Q51563594
Free insulin-like growth factors in human obesity.Q51585625
Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes.Q51594172
Aging is associated with decreased suppression of insulin-like growth factor binding protein-1 by insulin.Q51598608
High-calorie total parenteral nutrition reduces hepatic insulin-like growth factor-I mRNA and alters serum levels of insulin-like growth factor-binding protein-1, -3, -5, and -6 in the rat.Q53884376
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data GroupQ66972631
Insulin-like growth factor-binding protein-1 modulates blood glucose levelsQ67700946
Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factorQ71597507
Laboratory methods and quality assurance in the Cardiovascular Health StudyQ72588345
Regulation of IGF binding protein-1 in hep G2 cells by cytokines and reactive oxygen speciesQ74590968
Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndromeQ77969663
Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic strokeQ79691420
The insulin-like growth factor system and markers of inflammation in adult patients with inflammatory bowel diseaseQ81024332
Diagnosis and classification of diabetes mellitusQ82064791
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectglucose intoleranceQ2661464
P304page(s)166-173
P577publication date2007-09-27
P1433published inGrowth Hormone & I G F ResearchQ15766227
P1476titleInsulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults
P478volume18

Reverse relations

cites work (P2860)
Q34153541Association between serum IGF-1 and diabetes among U.S. adults.
Q43202934Associations between plasma insulin-like growth factor-I and the markers of inflammation interleukin 6, C-reactive protein and YKL-40 in an elderly background population
Q35626194Changes in insulin-like growth factor-I and its binding proteins are associated with diabetes mellitus in older adults
Q34310978Circulating IGF-axis protein levels and their relation with levels of plasma adipocytokines and macronutrient consumption in women
Q47754986Comparison of Intermittent Fasting Versus Caloric Restriction in Obese Subjects: A Two Year Follow-Up
Q88993170Composition and richness of the serum microbiome differ by age and link to systemic inflammation
Q46200583Effect of obesity and glycemic control on serum lipocalins and insulin-like growth factor axis in type 2 diabetic patients
Q34018992IGF-binding protein 1 and abdominal obesity in the development of type 2 diabetes in women
Q35857746Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis
Q35953962Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors
Q98465736Insulin-Like Growth Factor Gene Polymorphisms Predict Clinical Course in Allogeneic Hematopoietic Stem Cell Transplantation
Q36182551Insulin-like growth factor axis and risk of type 2 diabetes in women
Q37887276Insulin-like growth factor pathway: a link between androgen deprivation therapy (ADT), insulin resistance, and disease progression in patients with prostate cancer?
Q46581854Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men.
Q35409283Insulin-like growth factors and leukocyte telomere length: the cardiovascular health study
Q33736071Leukocyte telomere length associates with prospective mortality independent of immune-related parameters and known genetic markers
Q36029231Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes
Q50451678Oolong, black and pu-erh tea suppresses adiposity in mice via activation of AMP-activated protein kinase.
Q33791812Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741.
Q42880651RTEF-1 attenuates blood glucose levels by regulating insulin-like growth factor binding protein-1 in the endothelium
Q36842127Reciprocal association of plasma IGF-1 and interleukin-6 levels with cardiometabolic risk factors in nondiabetic subjects
Q37269401Role of IGF-1 in glucose regulation and cardiovascular disease
Q33559252Serum IGF-I and C-reactive protein in healthy black and white young men: the CARDIA male hormone study
Q37408256Serum insulin-like growth factor-1 binding proteins 1 and 2 and mortality in older adults: the Health, Aging, and Body Composition Study
Q47639338The Association Between IGF-I and IGFBP-3 and Incident Diabetes in an Older Population of Men and Women in the Cardiovascular Health Study
Q35747222The IGF-I regulatory system and its impact on skeletal and energy homeostasis
Q58568638The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes
Q34127704The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes
Q51822595Wanted: guidelines for reporting correlations.

Search more.